foxo4-dri senolytic peptide study 2017 The disordered p53 transactivation domain is the target of FOXO4 and the compound FOXO4-DRI (Proxofim) (10mg)
FOXO4 DRI (Proxofim) (10mg) FOXO4 DRI 10mg FOXO4 DRI For Sale (10mg) Core Peptides FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine
Pay in 4 interest-free payments of $6.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




